Reklāma

FWBI Forex ziņas

First Wave BioPharma To Sell Niclosamide Program To Undisclosed Biopharmaceutical Company

Biopharmaceutical company First Wave BioPharma, Inc. (FWBI) announced Wednesday that it has entered a non-binding term sheet to sell its Niclosamide program for the treatment of inflammatory bowel diseases (IBD) such as ulcerative colitis and related conditions to an undisclosed biopharmaceutical company.

RTTNews | 588 days ago

First Wave BioPharma To Acquire ImmunogenX In All-stock Transaction

Biopharmaceutical company First Wave BioPharma, Inc. (FWBI) announced Monday that the company has signed a non-binding term sheet to acquire biotherapeutics company ImmunogenX in an all-stock transaction.

RTTNews | 597 days ago

Noteikumi | Privātums | Lapas karte | Site Map Calendar

HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.

EURUSD	1.16268	GBPUSD	1.33221	AUDUSD	0.65015
USDJPY	147.387	USDCAD	1.3748	USDCHF	0.80612